RE104 Safety and Efficacy Study in Postpartum Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

June 14, 2024

Primary Completion Date

May 22, 2025

Study Completion Date

June 16, 2025

Conditions
Postpartum Depression
Interventions
DRUG

RE104 for Injection

Single, subcutaneous dose of RE104 for Injection

Trial Locations (38)

10016

Reunion Investigational Site, New York

10026

Reunion Investigational Site, New York

14202

Reunion Investigational Site, Buffalo

19380

Reunion Investigational Site, West Chester

20850

Reunion Investigational Site, Rockville

21205

Reunion Investigational Site, Baltimore

22903

Reunion Investigational Site, Charlottesville

27599

Reunion Investigational Site, Chapel Hill

28112

Reunion Investigational Site, Monroe

30030

Reunion Investigational Site, Decatur

30060

Reunion Investigational Site, Marietta

30329

Reunion Investigational Site, Atlanta

30331

Reunion Investigational Site, Atlanta

31405

Reunion Investigational Site, Savannah

33319

Reunion Investigational Site, Lauderhill

33613

Reunion Investigational Site, Tampa

35209

Reunion Investigational Site, Birmingham

43210

Reunion Investigational Site, Columbus

44113

Reunion Investigational Site, Cleveland

48377

Reunion Investigational Site, Novi

53719

Reunion Investigational Site, Madison

66160

Reunion Investigational Site, Kansas City

71106

Reunion Investigational Site, Shreveport

75093

Reunion Investigational Site, Plano

78229

Reunion Investigational Site, San Antonio

78712

Reunion Investigational Site, Austin

78737

Reunion Investigational Site, Austin

78759

Reunion Investigational Site, Austin

80045

Reunion Investigational Site, Boulder

80209

Reunion Investigational Site, Denver

84020

Reunion Investigational Site, Draper

84108

Reunion Investigational Site, Salt Lake City

85724

Reunion Investigational Site, Tucson

87131

Reunion Investigational Site, Albuquerque

90404

Reunion Investigational Site, Santa Monica

96817

Reunion Investigational Site, Honolulu

98105

Reunion Investigational Site, Seattle

01103

Reunion Investigational Site, Springfield

All Listed Sponsors
lead

Reunion Neuroscience Inc

INDUSTRY

NCT06342310 - RE104 Safety and Efficacy Study in Postpartum Depression | Biotech Hunter | Biotech Hunter